je.st
news
PharmaCyte Biotech's Diabetes Treatment to Be Presented at Austrodrugs 2015
2015-06-12 21:11:19| Biotech - Topix.net
PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , today reported that the company's diabetes treatment and the research program of its international Diabetes Consortium will be presented at the Austrodrugs 2015 conference to be held on June 12 in Vienna, Austria. The Austrodrugs conference is one of the leading disease treatment development meetings in central Europe.
Tags: presented
treatment
diabetes
biotechs
Category:Biotechnology and Pharmaceuticals